Steven R. Arikian
Plus aucun poste en cours
Profil
Steven R.
Arikian founded Genesis Research LLC, where he worked as Chairman.
Dr. Arikian also formerly worked at BioVest International, Inc., as Chairman, President & Chief Executive Officer from 2003 to 2008, Analytica International, Inc., as President & Chief Executive Officer, Bristol Myers Squibb Co., as President-Center Health Outcomes & Economics in 1997, and Accentia Biopharmaceuticals, Inc., as President & COO-Biopharmaceutical Products from 2002 to 2008.
Dr. Arikian received his undergraduate degree from Fordham University.
Anciens postes connus de Steven R. Arikian
Sociétés | Poste | Fin |
---|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Président | 02/12/2008 |
ACCENTIA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 02/12/2008 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/1997 |
Genesis Research LLC
Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Fondateur | - |
Analytica International, Inc.
Analytica International, Inc. Miscellaneous Commercial ServicesCommercial Services Analytica International, Inc. provides analytical and consulting services to the biopharmaceuticals industry. The company was founded on October 28, 2005 and is headquartered in New York, NY. | Directeur Général | - |
Formation de Steven R. Arikian
Fordham University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 4 |
---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
Analytica International, Inc.
Analytica International, Inc. Miscellaneous Commercial ServicesCommercial Services Analytica International, Inc. provides analytical and consulting services to the biopharmaceuticals industry. The company was founded on October 28, 2005 and is headquartered in New York, NY. | Commercial Services |
Genesis Research LLC
Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Commercial Services |